| 摘要 |
Pharmaceutical compositions for treating psychiatric disorders are provided. The compositions include 2-phenylethylamine ("PEA") and at least one inhibitor of monoamine oxidase B. Methods for the treatment of phychiatric disorders, including depression, panic disorders, and Parkinson's disease, using the disclosed pharmaceutical compositions are also provided.
|
